NCT00402883 2021-11-09
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Terminated
Clinical Trials
11 trialsNCT02795572 2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2 Terminated
NCT00243022 2019-04-30
Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT03778008 2018-12-27
Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis
Second Affiliated Hospital of Nanchang University
Phase 2 Unknown
NCT00227019 2017-03-06
Phase 2 Trial of Bevacizumab in Combination With Pemetrexed
Stanford University
Phase 2 Completed
NCT00216099 2016-07-29
Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer
Hoosier Cancer Research Network
Phase 2 Completed
NCT01194453 2016-06-16
AP/GP
Sun Yat-sen University
Phase 2 Completed
NCT02735317 2016-04-12
Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT
Sun Yat-sen University
Phase 2 Unknown
NCT01183065 2015-11-20
Study of Pralatrexate With Vitamin B12 and Folic Acid Supplementation for Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Cancer (HNSCC)
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01569919 2013-03-12
SKOPOS
Wales Cancer Trials Unit
Phase 2 Unknown
NCT00699478 2012-07-19
Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy
Yonsei University
Phase 2 Completed